Stay updated with breaking news from Randomised Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
The Independent Data Monitoring Committee recommended that the EMPA-KIDNEY trial be stopped early, following a formal interim assessmentEMPA-KIDNE...
The FINANCIAL -- The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when given to hospitalised patients with severe COVID-19. Baricitinib is an anti-inflammatory treatment normally used to treat rheumatoid arthritis. According to UKRI, the benefit was in addition to those of dexamethasone and tocilizumab, two other anti-inflammatory treatments that have previously beenThe FINANCIAL -- The RECOVERY trial has demonstrated that baricitinib reduces the risk of death when given to hospitalised patients with severe COVID-19. Baricitinib is an anti-inflammatory treatment n...
Rheumatoid arthritis drug baricitinib can reduce risk of death from severe Covid by about a fifth
Corticosteroids have been advised as a drug to target the host immune response in patients affected with severe lung inflammation due to COVID-19.